Published September 9, 2015 | Version v1
Journal article

S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma

  • 1. Centre for Cancer Biomarkers (CCBIO), Faculty of Medicine and Dentistry, University of Bergen, N-5021 Bergen (Norway)
  • 2. Department of Clinical Medicine, The Gade Laboratory for Pathology, University of Bergen, Haukeland University Hospital, N-5021 Bergen (Norway)
  • 3. Center of Medical Genetics and Molecular Medicine, Haukeland University Hospital, University of Bergen, N-5021 Bergen (Norway)
  • 4. Centre for Clinical and Diagnostic Oral Sciences, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, England (United Kingdom)
  • 5. Department of Pathology, Haukeland University Hospital, Bergen (Norway)

Description

Altered expression of S100A16 has been reported in human cancers, but its biological role in tumorigenesis is not fully understood. This study aimed to investigate the clinical significance and functional role of S100A16 in oral squamous cell carcinoma (OSCC) suppression. S100A16 mRNA and/or protein levels were examined by quantitative RT-PCR and immunohistochemistry in whole- and laser microdissected-specimens of normal human oral mucosa (NHOM, n = 65), oral dysplastic lesions (ODL, n = 21), OSCCs (n = 132) and positive cervical nodes (n = 17). S100A16 protein expression in OSCC was examined for correlations with clinicopathological variables and patient survival. S100A16 was over-expressed and knocked-down in OSCC-derived (CaLH3 and H357) cells by employing retroviral constructs to investigate its effects on cell proliferation, sphere formation and three dimensional (3D)-organotypic invasive abilities in vitro and tumorigenesis in a mouse xenograft model. Both S100A16 mRNA and protein levels were found to be progressively down-regulated from NHOM to ODL and OSCC. Low S100A16 protein levels in OSCC significantly correlated with reduced 10-year overall survival and poor tumor differentiation. Analysis of two external OSCC microarray datasets showed a positive correlation between the mRNA expression levels of S100A16 and keratinocyte differentiation markers. CaLH3 and H357 cell fractions enriched for differentiated cells either by lack of adherence to collagen IV or FACS sorting for low p75NTR expression expressed significantly higher S100A16 mRNA levels than the subpopulations enriched for less differentiated cells. Corroborating these findings, retroviral mediated S100A16 over-expression and knock-down in CaLH3 and H357 cells led to respective up- and down-regulation of differentiation markers. In vitro functional studies showed significant reduction in cell proliferation, sphere formation and 3D-invasive abilities of CaLH3 and H357 cells upon S100A16 over-expression. These functional effects were associated with concomitant down-regulation of self-renewal (Bmi-1 and Oct 4A) and invasion related (MMP1 and MMP9) molecules. S100A16 over-expression also suppressed tumorigenesis of H357 cells in a mouse xenograft model and the resulting tumor xenografts displayed features/expression of increased differentiation and reduced proliferation/self-renewal. These results indicate that S100A16 is a differentiation promoting protein and might function as a tumor suppressor in OSCC. The online version of this article (doi:10.1186/s12885-015-1622-1) contains supplementary material, which is available to authorized users

Availability note (English)

Available from http://dx.doi.org/10.1186/s12885-015-1622-1; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564982

Additional details

Publishing Information

Journal Title
BMC cancer (Online)
Journal Volume
15
Journal Page Range
vp.
ISSN
1471-2407

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47084218
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CARCINOMAS; CELL PROLIFERATION; IN VITRO; INHIBITION; MESSENGER-RNA; MUCOUS MEMBRANES; NITROGEN 21
Descriptors DEC
DISEASES; ISOTOPES; LIGHT NUCLEI; MEMBRANES; NEOPLASMS; NITROGEN ISOTOPES; NUCLEI; NUCLEIC ACIDS; ODD-EVEN NUCLEI; ORGANIC COMPOUNDS; RNA

Optional Information

Copyright
Copyright (c) Sapkota et al. 2015
Notes
PMCID: PMC4564982; PMID: 26353754; PUBLISHER-ID: 1622; OAI: oai:pubmedcentral.nih.gov:4564982